Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...
from NDTV News - Latest https://www.ndtv.com/india-news/cipla-set-to-launch-favipiravir-drug-for-treatment-of-covid-patients-2267973
No comments:
Post a Comment